SCHEMBL2303149

SCHEMBL2303149

O=C(O)CC(Cc1nc2ccc(Cl)cc2[nH]1)c1ccc(Br)cc1

nearest known ligand 0.77

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRKCZ Q05513 9/20 0.77
TDP1 Q9NUW8 1/20 0.49
RAB9A P51151 2/20 0.48
HSD17B10 Q99714 1/20 0.48
PIN1 Q13526 2/20 0.46
PTGFR P43088 2/20 0.42
EGLN1 Q9GZT9 1/20 0.42
F10 P00742 1/20 0.41
GABBR2 O75899 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD3 P35462 1/20 0.41
BLM P54132 1/20 0.41
GABBR1 Q9UBS5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2303759 0.93 PRKCZ (0.77) PRKCZTDP1RAB9AHSD17B10PTGFR
SCHEMBL659484 0.93 PRKCZ (0.83) PRKCZTDP1RAB9AHSD17B10PIN1
SCHEMBL2303141 0.91 PRKCZ (0.64) PRKCZTDP1RAB9AHSD17B10PTGFR
Hydrochloric Acid SCHEMBL658550 0.90 PRKCZ (0.62) PRKCZRAB9AHSD17B10PIN1PTGFR
SCHEMBL2304303 0.90 PRKCZ (0.78) PRKCZTDP1RAB9AHSD17B10PIN1
SCHEMBL2303682 0.88 PRKCZ (0.90) PRKCZTDP1RAB9AHSD17B10PIN1
SCHEMBL2303921 0.87 PRKCZ (1.00) PRKCZTDP1RAB9AHSD17B10PIN1
SCHEMBL2303754 0.87 PRKCZ (0.67) PRKCZRAB9APIN1PTGFRGABBR2
Hydrochloric Acid SCHEMBL655606 0.86 PRKCZ (0.66) PRKCZRAB9APIN1PTGFRGABBR2
SCHEMBL2302726 0.85 PRKCZ (0.78) PRKCZTDP1RAB9AHSD17B10PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP claimed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO claimed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PRKCZ 26/4885TDP1 992/4885RAB9A 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.